Skip to main content

Table 2 Isolates of microorganisms from patients’ sample culture

From: Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience

Organism

Total

Cefepime

Meropenem

Piperacillin/tazobactam

Staphylococcus

8 (25.00)

6 (50.00)

0 (0.00)

2 (22.22)

E. coli

7 (21.88)

1 (8.33)

3 (27.27)

3 (33.33)

Klebsiella

5 (15.63)

0 (0.00)

3 (27.27)

2 (22.22)

Enterococci

3 (9.38)

3 (25.00)

0 (0.00)

0 (0.00)

Citrobacter

2 (6.25)

1 (8.33)

1 (9.09)

0 (0.00)

Enterobacter

2 (6.25)

0 (0.00)

1 (9.09)

1 (11.11)

Pseudomonas

2 (6.25)

1 (8.33)

1 (9.09)

0 (0.00)

Streptococcus

1 (3.13)

0 (0.00)

1 (9.09)

0 (0.00)

Candida

2 (6.25)

0 (0.00)

1 (9.09)

1 (11.11)

  1. Treatment efficacy